Fuzzy set analyses of genetic determinants of health and disability status

Statistical Methods in Medical Research

Volumn 13, Issue 5, 2004, Pages 395-408

  Manton, Kenneth G ^a   Gu, Xiliang ^a   Huang, Hai ^a   Kovtun, Mikhail ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; ANALYTICAL ERROR; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DISABILITY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HEALTH STATUS; HEALTH SURVEY; HUMAN; LONG TERM CARE; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PROTEIN ANALYSIS; PROTEIN POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL MODEL; STOCHASTIC MODEL;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; DISABLED PERSONS; FEMALE; FUZZY LOGIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEALTH STATUS; HUMANS; MALE; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; PHENOTYPE; STOCHASTIC PROCESSES;

EID: 6444244217     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1191/0962280204sm374ra     Document Type: Article

References (58)

1. Golubovsky M, Manton K. Three-generation approach in biodemography based on developmental profile and epigenetics of female gametes. Frontier in Bioscience Encyclopedia, 2004, in press.
2. Finch C, Kirkwood T. Chance, development, and aging. Oxford and New York: Oxford University Press, 2000.
3. Manton KG, Woodbury MA, Tolley HD. Statistical applications using fuzzy Sets. New York: John Wiley & Sons, 1994.
4. Manton KG, Korten A, Woodbury MA, Anker K, Jablensky A. Symptom profiles of psychiatric disorders based on graded disease classes: an illustration using data from the WHO International Pilot Study of Schizophrenia. Psychological Medicine 1994; 24: 133-44.
5. Cohen HJ, Cox E, Manton KG, Woodbury MA. Malignant melanoma in the elderly. Journal Clinical Oncology 1987; 5 (1): 100-106.
6. Manton KG, Land KC. Multidimensional disability/mortality trajectories at ages 65 and over: the impact of state dependence. Social Indicators Research 2000; 51 (2): 193-221.
7. Manton KG, Cornelius ES, Woodbury MA. Nursing home residents: a multivariate analysis of their medical, behavioral, psychosocial and service use characteristics. Journal of Gerontology: Biological Sciences and Medical Sciences 1995; 50 (5): M242-M51.
8. Anderson T. An introduction to multivariate statistical analysis. New York: John Wiley and Sons, 1958.
9. Lazarsfeld P, Henry N. Latent structure analysis. Boston: Houghton Mifflin, 1968.
10. Haberman S. Statistical applications using fuzzy sets by Manton KG, Woodbury MA, Tolley HD. Journal of the American Statistical Association, Alexandria 1995; 90 (431): 1131.
11. Kovtun M, Akushevich I, Manton KG, Tolley HD. Grade of Membership Analysis: One Possible Approach to Foundations. Invited paper for Focus on Probability Theory, Nova Science Publishers, NY, 2004 in press. Available at http://uk.arxiv.org/PS_cache/pdf/0403/0403373.pdf or http://uk.arxiv.org/abs/math/0403373
12. Scott J, Knott TJ, Shaw DJ, Brook JD. Localization of gene encoding apolipoproteins CI, CII, and E to the p13 → cen region of human chromosome 19. Human Genetics 1985; 71: 144-46.
13. Weisgraber KH, Rall SC, Mahley RW. Human E apoprotein heterogeneity: cysteine-arginine interchanges in the amino acid sequence of the apo E isoforms. The Journal of Biology Chemistry 1981; 256: 9077-83.
14. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. American Journal of Epidemiology 2002; 155 (6 : 487-95.
15. Hanis CL, Hewett-Emmett D, Douglas TC, Bertin TK, Schull WJ. Effects of the apolipoprotein E polymorphism on levels of lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas. Arteriosclerosis, Thrombosis and Vascular Biology 1991; 11: 362-70.
16. Kamboh MI, Sepehrnia B, Ferrell RE. Genetic studies of human apolipoproteins VI. Common polymorphism of apolipoprotein E in blacks. Disease Markers 1989; 7: 49-55.
17. Howard BV, Gidding SS, Lui K. Association of apolipoprotein E phenotype with plasma lipoproteins in African-American and white young adults: the CARDIA Study. Coronary Artery Risk Development in Young Adults. American Journal of Epidemiology 1998; 148: 859-68.
18. Kataoka S, Robbins DC, Cowan LD. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes: the Strong Heart Study. Arteriosclerosis, Thrombosis and Vascular Biology 1996; 16: 918-25.
19. Schaefer EJ, Lamon-Fava S, Johnson S. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels: results from the Framingham Offspring Study. Arteriosclerosis, Thrombosis and Vascular Biology 1994; 14: 1105-13.
20. Assmann G, Schmitz G, Menzel HJ, Schulte H. Apolipoprotein E polymorphism and hyperlipidemia. Clinical Chemistry 1984; 30: 641-43.
21. Lehtimäki T, Moilanen T, Viikari J, Akerblom HK, Ehnholm C, Ronnemaa T, Marniemi J, Dahlen G, Nikkari T. Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. Journal of Lipid Research 1990; 31: 487-95.
22. Luc G, Bard JM, Arveiler D, Evans A, Cambou JP. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arteriosclerosis, Thrombosis and Vascular Biology 1994; 14: 1412-19.
23. Cattin L, Fisicaro M, Tonizzo M, Valenti M, Danek GM, Fonda M, Da Col PG, Casagrande S, Pincetri E, Bovenzi M, Baralle F. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults. Arteriosclerosis, Thrombosis and Vascular Biology 1997; 17: 91-94.
24. Evans AE, Zhang W, Moreel JF, Bard JM, Ricard S, Poirier O, Tiret L, Fruchart JC, Cambien F. Polymorphisms of the apolipoprotein B and E genes and their relationship to plasma lipid variables in healthy Chinese men. Human Genetics 1993; 92: 191-97.
25. Eto M, Watanabe K, Makino I. Increased frequencies of apolipoprotein E2 and E4 alleles in patients with ischemic heart disease. Clinical Genetics 1989; 36: 183-88.
26. Jarvik GP. Genetic predictors of common disease: apolipoprotein E genotype as a paradigm. Annals of Epidemiology 1997; 7 (5): 357-62.
27. Stengard JH, Weiss KM, Sing CF. An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Human Genetics 1998; 103: 234-41.
28. Eichner JE, Kuller LH, Orchard TJ, Ferrell RE, Neaton JD. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. The American Journal of Cardiology 1993; 71 160-65
29. Lehtinen S, Lehtimaki T, Sisto T, Salenius JP, Nikkila M, Jokela H, Koivula T, Ebeling F, Ehnholm C. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiography verified coronary artery disease in men and women. Atherosclerosis 1995; 114: 83-91.
30. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderlyFinnish men. Circulation 1995; 91:: 265-69.
31. Wang XL, McCredie RM, Wilcken DEL. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arteriosclerosis, Thrombosis and Vascular Biology 1995; 15: 1030-34.
32. Yoshida H, Hasty AH, Major AS, Ishiguro H, Su YR, Gleaves LA, Babaev VR, Linton MF, Fazio S. Isoform-specific effects of apolipoprotein E on atherosclerosis. Gene transduction studies in mice. Circulation 2001; 104: 2820-25.
33. Murphy MM, Vilella E, Ceruelo S, Figuera L, Sanchez M, Camps J, Cuco G, Ferré N, Labad A, Tasevska N, Arija V, Joven J, Fernandez-Ballart J. The MTHFR C677T, APOE, and PON55 gene polymorphisms show relevant interactions with cardiovascular risk factors. Clinical Chemistry 2002; 48: 372-75.
34. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ. Association of apolipoprotein E allele [epsilon]4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-72.
35. Myhre A, Tysnes OB: Etiology and genetics of Alzheimer disease. Tidsskrift for den Norske laegeforenin 2002; 122: 50-53.
36. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D. Genetic associations with human longevity at the apo E and ACE loci. Nature Genetics 1994; 6: 29-32.
37. Juvonen T, Kervinen K, Kairaluoma MI, Lajunen LH, Kesaniemi YA. Gallstone cholesterol content is related to apolipoprotein E polymorphism. Gastroenterology 1993; 104: 1806-13.
38. Van Erpecum KJ, Carey MC. Apolipoprotein E4 another risk factor for cholesterol gallstone formation? Gastroenterology 1996; 111: 1764-67.
39. Kervinen K, Sodervik H, Makela J, Lehtola J, Niemi M, Kairaluoma MI, Kesaniemi YA. Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology 1996; 110: 1785-90.
40. Zunarelli E, Nicoll JA, Migaldi M, Trentini GP. Apolipoprotein E polymorphism and breast carcinoma: correlation with cell proliferation indices and clinical outcome. Breast Cancer Research and Treatment 2000; 63: 193-98.
41. Zunarelli E, Nicoll JA, Trentini GP. Apolipoprotein E polymorphism and central nervous system tumors: correlation with cell proliferation indices and clinical outcome. Clinical Neuropathology 2000; 19: 1-6.
42. Carlin C, Murray L, Graham D, Doyle D, Nicoll, J. Involvement of apolipoprotein E in multiple sclerosis: Absence of remyelination associated with possession of the Apo E epsilon2 allele. Journal of Neuropathology and Experimental Neurology 2000; 59: 361-67.
43. McCarron MO, Nicoll JA. Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage. Annals of the New York Academy of Science 2000; 903: 176-79.
44. Nicoll JAR, McCarron MO. APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage. Amyloid 2001; 8 (1): 51-55.
45. Grocott HP, Newman MF, EI-Moalem H, Bainbridge D, Butler A, Laskowitz DT. Apolipoprotein E genotype differentially influences the proinflammatory and antiinflammatory response to cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery 2001; 122: 622-23.
46. Broderick J, Lu M, Jackson C, Pancioli A, Tilley BC, Fagan SC, Kothari R, Levine SR, Marler JR, Lyden PD, Haley EC, Jr., Brott T, Grotta JC, and the NINDS t-PA Stroke Study Group. Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke. Annals of Neurology 2001; 49: 736-44.
47. Ballantyne CM, Herd JA, Stein EA, Ferlic LL, Dunn JK, Gotto AM, Jr., Marian AJ. Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy. Journal of the American College of Cardiology 2000; 36: 1572-78.
48. Corella D, Tucker K, Lahoz C, Coltell O, Cupples LA, Wilson PW, Schaefer EJ, Ordovas JM. Alcohol drinking determines the effect of the apo E locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study. The American Journal of Clinical Nutrition 2001; 73: 736-45.
49. Wilson RS, Bienias JL, Berry-Kravis E, Evans DA, Bennett DA. The apolipoprotein E E2 allele and decline in episodic memory. Journal of Neurology Neurosurgery and Psychiatry 2002; 73 (6): 672-77.
50. den Heijer T, Oudkerk M, Launer LJ, van Duijn CM, Hofman A, and Breteler MMB. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology 2002; 59: 746-68.
51. Laviolette M, Seaman J, Barrett J, Woodall W. A probabilistic and statistical view of fuzzy methods. Technometrics 1995; 37 249-61.
52. Laviolette M, Seaman J, Barrett D, Woodall W. A probabilistic and statistical view of fuzzy methods, and subsequent discussions and reply. Technometrics 1995; 37: 287-92.
53. Kiefer J, Wolfowitz J. Consistency of the maximum likelihood estimator in the presence of infinitely many parameters. Annals of Mathematical Statistics 1956; 27: 887-906.
54. Everitt B. An introduction to latent variable models. London, New York: Chapman and Hall, 1984.
55. Press WH, Flannery BP, Teukolsky SA, Vetterling WT. Numerical recipes in FORTRAN, the art of scientific computing. Cambridge: Cambridge University Press, 1992.
56. Berkman L, Singer B, Manton KG. Black/white differences in health status and mortality among the elderly. Demography 1989; 26 (4): 661-78.
57. Emi M, Wu LL, Robertson MA, Myers RL, Hegele RA, Williams RR, White R, Lalouel JM. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 1988; 3 (4): 373-79.
58. Van de Geer JP. Introduction to multivariate analysis for the social sciences. San Francisco: Freeman WH, 1971.